Immunology/Inflammation
Read More about this categoryShow Less
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
Research Areas
- 5-Lipoxygenase(17)
- Apoptosis(753)
- Cyclic GMP-AMP Synthase(6)
- TLR(124)
- Papain(1)
- PGDS(1)
- PGE synthase(26)
- SIKs(12)
- IκB/IKK(68)
- AP-1(14)
- KEAP1-Nrf2(58)
- NOD1(1)
- NF-κB(312)
- Interleukin Related(303)
- 15-lipoxygenase(2)
- Others(10)
- Aryl Hydrocarbon Receptor(42)
- CD73(17)
- Complement System(74)
- Galectin(13)
- IFNAR(60)
- NO Synthase(95)
- NOD-like Receptor (NLR)(68)
- STING(120)
- Reactive Oxygen Species(522)
- FKBP(16)
- eNOS(4)
- iNOS(29)
- nNOS(20)
- Glutathione(54)
- Adaptive Immunity(210)
- Allergy(118)
- Arthritis(34)
- Autoimmunity(181)
- Gastric Disease(94)
- Immunosuppressants(38)
- Immunotherapeutics(4)
- Innate Immunity(566)
- Pulmonary Diseases(109)
- Reactive Nitrogen Species(50)
- Specialized Pro-Resolving Mediators(49)
- Reactive Sulfur Species(28)
- BCL6(8)
- CD20(14)
- CD28(4)
- PSMA(15)
- FAP(24)
- Nuclear Factor of activated T Cells (NFAT)(2)
- Glycoprotein VI(2)
- Tim3(4)
- Hapten(1)
- Nectin-4(3)
- DOCK(4)
- MHC(10)
- Transmembrane Glycoprotein(31)
- TREM receptor(11)
- Inflammation or Immune System Disease(2)
- Musculoskeletal and Skin Disease(1)
- Fc Receptor (FcR)(12)
- IKZF Family(5)
- C-type Lectin-like Receptors (CTLRs)(9)
- Asialoglycoprotein Receptor (ASGPR)(3)
- Human leukocyte immunoglobulin (Ig)-like receptors (LILR)(1)
Products Related to Immunology/Inflammation(4623)
- GC79326Tirzepatide sodiumPurity: >98.00%
Tirzepatide sodium (LY3298176 sodium) is a dual glucose-dependent insulinotropic polypeptide ( GIP ) and glucagon-like peptide-1 ( GLP-1 ) receptor agonist.
- GC79327BMS-986331CAS: 2375684-52-7Purity: >99.50%
BMS-986331 is an orally active selective N-Formyl Peptide Receptor 2 (FPR2) agonist with an EC 50 of 0.5 nM in humans and 1 nM in rats.
- GC79329VCAM1 binding peptide acetatePurity: >99.50%
VCAM1 binding peptide acetate is a VCAM1 binder with internalization activity.
- GC79330Pseudoginsenoside RT4CAS: 98474-77-2Purity: >97.00%
Pseudoginsenoside RT4 is an orally active anti-inflammatory agent.
- GC79331OxyacanthineCAS: 548-40-3Purity: >98.00%
Oxyacanthine is a bisbenzylisoquinoline alkaloid and anti-inflammatory agent.
- GC79334ZareprumigCAS: 3062698-53-4Purity: >95.00%
Zareprumig is a human monoclonal antibody targeting CD20/MS4A1&CD71/TFRC [1] .
- GC79336TLR9 antagonist 1 diformatePurity: >98.00%
TLR9 antagonist 1 diformate is a selective hTLR9 antagonist with an IC 50 of 0.1 nM against hTLR9.
- GC79338PL120131 acetatePurity: >99.50%
PL120131 acetate is a PD-1 antagonist, can specifically blocking the interaction between PD-1 and PD-L1, thereby effectively inhibiting the PD-1-mediated apoptosis signaling pathway.
- GC79339Anti-CD160 Antibody (MAT 302)Purity: >97.00%
Anti-CD160 Antibody (MAT 302) (CL1-R2) is a human monoclonal antibody targeting CD160.
- GC79340Anti-Mouse TREM2 Antibody (178)Purity: >98.50%
Anti-Mouse TREM2 Antibody (178) is an antibody targeting mouse TREM2, which blocks the binding of ligands to TREM2 and inhibits TREM2 -mediated signaling pathways.
- GC79341N-MethylscatoleCAS: 875-30-9Purity: >98.00%
N-Methylscatole (compound 70130) is a weak aryl hydrocarbon receptor ( AhR ) agonist exhibiting no significant antagonistic activity [1] .
- GC793429,10-DichlorophenanthreneCAS: 17219-94-2Purity: >98%
9,10-Dichlorophenanthrene is a chlorinated polycyclic aromatic hydrocarbon and is generally regarded as a carcinogen.
- GC79345BlidarvetugCAS: 3056024-36-0Purity: >99.00%
Blidarvetug is a veterinary monoclonal antibody targeting MS4A1/CD20, which can be used to study CD20-positive B-cell lymphoma in dogs.
- GC79346Zemlikafusp alfaPurity: >97.00%
Zemlikafusp alfa (IPH6501) is a tetra-specific NK cell engager that targets CD20, CD16a, NKp46 and carries an IL-2 variant.
- GC79348RadanstobartCAS: 3064483-12-8Purity: >99.00%
Radanstobart (HFB-200603) is a humanized monoclonal antibody targeting CD272 with antitumor activity.
- GC79349Anti-CD80 Antibody (TKMF5)Purity: >96.50%
Anti-CD80 Antibody (TKMF5) is an antibody against human CD80.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC79292 | PG-901 | 322639-20-3 | >99.00% | |
PG-901 is a full, selective MC5R agonist ( EC 50 = 0.072 nM for hMC5R). | ||||
| GC79293 | PIPE-791 | 2901868-37-7 | >98% | |
PIPE-791 is an orally active, blood-brain barrier-permeable selective antagonist of LPAR1. | ||||
| GC79300 | XAT-14 | 3107904-59-3 | >98.50% | |
XAT-14 is a Furanocoumarin derivative. | ||||
| GC79326 | Tirzepatide sodium | - | >98.00% | |
Tirzepatide sodium (LY3298176 sodium) is a dual glucose-dependent insulinotropic polypeptide ( GIP ) and glucagon-like peptide-1 ( GLP-1 ) receptor agonist. | ||||
| GC79327 | BMS-986331 | 2375684-52-7 | >99.50% | |
BMS-986331 is an orally active selective N-Formyl Peptide Receptor 2 (FPR2) agonist with an EC 50 of 0.5 nM in humans and 1 nM in rats. | ||||
| GC79329 | VCAM1 binding peptide acetate | - | >99.50% | |
VCAM1 binding peptide acetate is a VCAM1 binder with internalization activity. | ||||
| GC79330 | Pseudoginsenoside RT4 | 98474-77-2 | >97.00% | |
Pseudoginsenoside RT4 is an orally active anti-inflammatory agent. | ||||
| GC79331 | Oxyacanthine | 548-40-3 | >98.00% | |
Oxyacanthine is a bisbenzylisoquinoline alkaloid and anti-inflammatory agent. | ||||
| GC79332 | HTS10307 | 81682-91-9 | >98% | |
HTS10307 is a small molecule AP1 Transcription Factor ΔFOSB inhibitor. | ||||
| GC79333 | JPC0661 | 30479-81-3 | >98% | |
JPC0661 is a direct and allosteric ΔFOSB inhibitor. | ||||
| GC79334 | Zareprumig | 3062698-53-4 | >95.00% | |
Zareprumig is a human monoclonal antibody targeting CD20/MS4A1&CD71/TFRC [1] . | ||||
| GC79335 | LC-PDA-01 | - | >98% | |
LC-PDA-01 is a selective peroxiredoxin 1 (PRDX1) activator with an EC 50 of 111.8 nM and a human K D of 123.2 nM. | ||||
| GC79336 | TLR9 antagonist 1 diformate | - | >98.00% | |
TLR9 antagonist 1 diformate is a selective hTLR9 antagonist with an IC 50 of 0.1 nM against hTLR9. | ||||
| GC79337 | ZSTK3744 | - | >98.00% | |
ZSTK3744 is an aryl hydrocarbon receptor ( AhR ) agonist. | ||||
| GC79338 | PL120131 acetate | - | >99.50% | |
PL120131 acetate is a PD-1 antagonist, can specifically blocking the interaction between PD-1 and PD-L1, thereby effectively inhibiting the PD-1-mediated apoptosis signaling pathway. | ||||
| GC79339 | Anti-CD160 Antibody (MAT 302) | - | >97.00% | |
Anti-CD160 Antibody (MAT 302) (CL1-R2) is a human monoclonal antibody targeting CD160. | ||||
| GC79340 | Anti-Mouse TREM2 Antibody (178) | - | >98.50% | |
Anti-Mouse TREM2 Antibody (178) is an antibody targeting mouse TREM2, which blocks the binding of ligands to TREM2 and inhibits TREM2 -mediated signaling pathways. | ||||
| GC79341 | N-Methylscatole | 875-30-9 | >98.00% | |
N-Methylscatole (compound 70130) is a weak aryl hydrocarbon receptor ( AhR ) agonist exhibiting no significant antagonistic activity [1] . | ||||
| GC79342 | 9,10-Dichlorophenanthrene | 17219-94-2 | >98% | |
9,10-Dichlorophenanthrene is a chlorinated polycyclic aromatic hydrocarbon and is generally regarded as a carcinogen. | ||||
| GC79345 | Blidarvetug | 3056024-36-0 | >99.00% | |
Blidarvetug is a veterinary monoclonal antibody targeting MS4A1/CD20, which can be used to study CD20-positive B-cell lymphoma in dogs. | ||||
| GC79346 | Zemlikafusp alfa | - | >97.00% | |
Zemlikafusp alfa (IPH6501) is a tetra-specific NK cell engager that targets CD20, CD16a, NKp46 and carries an IL-2 variant. | ||||
| GC79347 | AL044 | - | >97.00% | |
AL044 is an antibody targeting MS4A family proteins. | ||||
| GC79348 | Radanstobart | 3064483-12-8 | >99.00% | |
Radanstobart (HFB-200603) is a humanized monoclonal antibody targeting CD272 with antitumor activity. | ||||
| GC79349 | Anti-CD80 Antibody (TKMF5) | - | >96.50% | |
Anti-CD80 Antibody (TKMF5) is an antibody against human CD80. | ||||
